JP6538071B2 - 非天然発生のブタ生殖器呼吸器症候群ウイルス（ｐｒｒｓｖ）及び使用する方法 - Google Patents

非天然発生のブタ生殖器呼吸器症候群ウイルス（ｐｒｒｓｖ）及び使用する方法 Download PDF

Info

Publication number
JP6538071B2
JP6538071B2 JP2016559325A JP2016559325A JP6538071B2 JP 6538071 B2 JP6538071 B2 JP 6538071B2 JP 2016559325 A JP2016559325 A JP 2016559325A JP 2016559325 A JP2016559325 A JP 2016559325A JP 6538071 B2 JP6538071 B2 JP 6538071B2
Authority
JP
Japan
Prior art keywords
prrsv
nucleic acid
con
seq
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016559325A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017510276A5 (enExample
JP2017510276A (ja
Inventor
ヒープ・ライ・シュアン・ヴ
フェルナンド・オソリオ
ウィリアム・ダブリュー・レイグリード
アシット・ケー・パトナイク
ファンルイ・マ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois System
Original Assignee
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois System filed Critical University of Illinois System
Publication of JP2017510276A publication Critical patent/JP2017510276A/ja
Publication of JP2017510276A5 publication Critical patent/JP2017510276A5/ja
Application granted granted Critical
Publication of JP6538071B2 publication Critical patent/JP6538071B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016559325A 2014-03-21 2015-03-25 非天然発生のブタ生殖器呼吸器症候群ウイルス（ｐｒｒｓｖ）及び使用する方法 Active JP6538071B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461968465P 2014-03-21 2014-03-21
PCT/IB2015/052214 WO2015140774A1 (en) 2014-03-21 2015-03-25 A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Publications (3)

Publication Number Publication Date
JP2017510276A JP2017510276A (ja) 2017-04-13
JP2017510276A5 JP2017510276A5 (enExample) 2017-09-14
JP6538071B2 true JP6538071B2 (ja) 2019-07-03

Family

ID=54143830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016559325A Active JP6538071B2 (ja) 2014-03-21 2015-03-25 非天然発生のブタ生殖器呼吸器症候群ウイルス（ｐｒｒｓｖ）及び使用する方法

Country Status (11)

Country Link
US (3) US10072046B2 (enExample)
EP (1) EP3119429A4 (enExample)
JP (1) JP6538071B2 (enExample)
KR (1) KR20170002393A (enExample)
CN (1) CN107635579A (enExample)
CA (1) CA2943478A1 (enExample)
HK (1) HK1247128A1 (enExample)
MX (1) MX378873B (enExample)
PH (2) PH12016501854A1 (enExample)
RU (1) RU2687150C2 (enExample)
WO (1) WO2015140774A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2943478A1 (en) * 2014-03-21 2015-09-24 Nutech Ventures A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using
TWI704225B (zh) * 2016-02-18 2020-09-11 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
WO2022211482A1 (ko) * 2021-03-31 2022-10-06 충남대학교 산학협력단 바이러스 표면 엔지니어링 기반의 면역 증강된 바이러스 백신
CN118791578B (zh) * 2024-07-29 2024-12-27 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 猪繁殖与呼吸综合征病毒nsp12蛋白的抗原表位、单克隆抗体及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
RU2220978C2 (ru) * 1997-05-06 2004-01-10 Стихтинг Динст Ландбаувкюндиг Ондерзук Пептид, индуцирующий образование антител, которые реагируют с двумя различными изолятами вррсс (варианты), иммуногенная композиция, вакцина для профилактики заражения репродуктивно-респираторным синдромом свиней, антитело, диагностический набор (варианты)
DE60044672D1 (de) * 1999-04-22 2010-08-26 Boehringer Ingelheim Vetmed Auf dem isolat ja-142 basierender impfstoff gegen das reproduktive-und-respiratorische syndrom beim schwein
AU2001228502A1 (en) * 2000-01-26 2001-08-07 Boehringer Ingelheim Vetmedica Gmbh Recombinant attenuation of prrsv
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
DK1929047T3 (da) 2005-08-30 2010-07-12 Univ Nebraska Fremgangsmåder og sammensætninger til vaccination af dyr med PRRSV-antigener med forbedret immunogenicitet
CA2630648C (en) * 2005-11-29 2016-01-19 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2737058A1 (en) * 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
EP2620446A1 (en) * 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
CA2943478A1 (en) * 2014-03-21 2015-09-24 Nutech Ventures A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using

Also Published As

Publication number Publication date
US20170198016A1 (en) 2017-07-13
MX378873B (es) 2025-03-11
JP2017510276A (ja) 2017-04-13
RU2687150C2 (ru) 2019-05-07
RU2016141287A (ru) 2018-04-26
EP3119429A4 (en) 2018-04-04
WO2015140774A1 (en) 2015-09-24
KR20170002393A (ko) 2017-01-06
CA2943478A1 (en) 2015-09-24
US11136355B2 (en) 2021-10-05
PH12016501854B1 (en) 2017-01-09
US10072046B2 (en) 2018-09-11
CN107635579A (zh) 2018-01-26
US20200331970A1 (en) 2020-10-22
RU2016141287A3 (enExample) 2018-06-07
HK1247128A1 (zh) 2018-09-21
US20190048042A1 (en) 2019-02-14
PH12020550204A1 (en) 2021-01-11
MX2016012276A (es) 2017-06-12
US10738088B2 (en) 2020-08-11
EP3119429A1 (en) 2017-01-25
PH12016501854A1 (en) 2017-01-09

Similar Documents

Publication Publication Date Title
ES2971606T3 (es) Cepa atenuada del virus de la peste porcina africana desarrollada racionalmente que protege contra la exposición al aislado del virus parental Georgia 2007
AU2016225119B2 (en) Porcine Epidemic Diarrhea Virus strains and immunogenic compositions therefrom
JP5893829B2 (ja) イヌパルボウイルス遺伝子変異株を含むワクチン
KR20220132588A (ko) 탈최적화된 SARS-CoV-2 및 이의 방법 및 용도
CN110551695A (zh) 非洲猪瘟病毒四基因缺失弱毒株及其应用
KR20170032441A (ko) 코로나바이러스
US11136355B2 (en) Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using
JP2012519471A (ja) 北米のイヌにおいて広まっているイヌジステンパーウイルスに基づく免疫原性組成物、ワクチンおよび診断法
CN112063592A (zh) 非洲猪瘟多基因联合缺失减毒株的构建及作为疫苗的应用
Tao et al. Identification and genetic characterization of new bovine viral diarrhea virus genotype 2 strains in pigs isolated in China
CN114015660B (zh) 缺失十个基因的减毒非洲猪瘟病毒株的构建及其作为疫苗的应用
WO2020238458A1 (zh) 用于表达e2蛋白的细胞株及其应用，e2蛋白及其应用
CN112057611B (zh) 非洲猪瘟病毒e120r蛋白作为免疫抑制剂的应用及免疫抑制位点敲除毒株的构建
JP2022507053A (ja) 新規ブタロタウイルス
CN106244602A (zh) 一种携带两个g基因和vp2基因的重组狂犬病病毒及其应用
CN117778334A (zh) 表达猪瘟病毒e2蛋白的重组猪伪狂犬病毒株及其制备方法和应用
CN101257917A (zh) 针对黄病毒科病毒感染的嵌合多肽及其治疗应用
Lai Xuan Vu et al. NON-NATURALLY OCCURRING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND METHODS OF USING
CN115927416B (zh) 嵌合猪瘟病毒、猪瘟标记疫苗及其制备方法和应用
Xuan Vu et al. NON-NATURALLY OCCURRING PORCINE REPRODUCTION AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND METHODS OF USING
JP2022521463A (ja) 新規魚トティウイルス
CN113308440B (zh) 一种n7-甲基转移酶缺陷型冠状病毒减毒疫苗株及其制备方法与应用
Sepotokele Production of plant-expressed virus-like particle vaccines against infectious bronchitis coronavirus and vaccine efficacy in chickens
JP2022520756A (ja) 新規魚コロナウイルス
Ohe et al. Search of the Infections Source of feline calicivirus in a Multicat Household

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170801

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190411

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190507

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190605

R150 Certificate of patent or registration of utility model

Ref document number: 6538071

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250